Lung structure and longitudinal change in cardiac structure and function: the MESA COPD Study
- PMID: 39362671
- PMCID: PMC12120402
- DOI: 10.1183/13993003.00820-2024
Lung structure and longitudinal change in cardiac structure and function: the MESA COPD Study
Abstract
Background: Lung structure and cardiac structure and function are associated cross-sectionally. The classic literature suggests relationships of airways disease to cor pulmonale and emphysema to reduced cardiac output (CO) but longitudinal data are lacking.
Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study was a multicentre longitudinal COPD case-control study of participants 50-79 years with ≥10 pack-years smoking without clinical cardiovascular disease. Segmental airway wall area (WA) and percent emphysema were measured on computed tomography. Right and left ventricle parameters were assessed on cardiac magnetic resonance imaging (cMRI) in exams 6 years apart. Longitudinal and period cross-sectional associations were evaluated with mixed models adjusted for demographics, body size and smoking.
Results: The 187 participants with repeated cMRI were 67±7 years old; 42% had COPD; 22% currently smoked; and the race/ethnicity distribution was 54% White, 30% Black, 14% Hispanic and 3% Asian. Greater WA at enrolment was associated with longitudinal increase in right ventricular (RV) mass (3.5 (95% CI 1.1-5.9) g per 10 mm2 WA). Greater percent emphysema was associated with stably lower left ventricular (LV) end-diastolic volume (-7.8 (95% CI -10.3- -3.0) mL per 5% emphysema) and CO (-0.2 (95% CI -0.4- -0.1) L·min-1 per 5% emphysema).
Conclusion: Cardiac associations varied by lung structure over 6 years in this multi-ethnic study. Greater WA at enrolment was associated with longitudinal increases in RV mass, whereas greater percent emphysema was associated with stable decrements in LV filling and CO.
Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.
Conflict of interest statement
Conflict of interest: E.A. Hoffman is a founder and shareholder of VIDA Diagnostics. The remaining authors have no related conflicts of interest to disclose.
Figures



Comment in
-
The lung that rules the heart.Eur Respir J. 2024 Dec 12;64(6):2401922. doi: 10.1183/13993003.01922-2024. Print 2024 Dec. Eur Respir J. 2024. PMID: 39667781 No abstract available.
References
-
- Organization WH. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2019. Geneva: 2020.
-
- Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2024 Report: GOLD Executive Summary. https://goldcopdorg/2024-gold-report 2024. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- N01 HC095161/HL/NHLBI NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- R01 HL093081/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- R01 HL075476/HL/NHLBI NIH HHS/United States
- R01 HL130506/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- P30 ES005605/ES/NIEHS NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous